Yadvinder Bhuller, Marc Avey, Raywat Deonandan, et al. Ethical principles for regulatory risk decision-making. Regulatory Toxicology and Pharmacology. 2025:105813. doi:10.1016/j.yrtph.2025.105813
U.S. National Institutes of Health. NIH to prioritize human-based research technologies. https://www.nih.gov/news-events/news-releases/nih-prioritize-human-based-research-technologies. Published 2025.
Jennifer Bell, Vanessa Zaiatz Bittencourt. Dealing with animal death and writing about it: Cultivating resilience in biotechnology writing. Medical Writing. 2025;34(1):70-73. https://journal.emwa.org/rare-diseases/biotechnology/.
Laurence Walder, Giorgia Pallocca, LuÃsa F. Bastos, et al. EU roadmap for phasing out animal testing for chemical safety assessments: Recommendations from a multi-stakeholder roundtable. ALTEX - Alternatives to animal experimentation. 2025. doi:10.14573/altex.2503241
Thomas Hartung. The turning point: April 2025 marks historic shift in US animal testing policy. ALTEX - Alternatives to animal experimentation. 2025. doi:10.14573/altex.2504301
Pandora Pound. Release the Beast. https://themedicinemaker.com/discovery-development/the-increasingly-sensible-case-against-the-use-of-animal-research. Published 2024.
Jarrod Bailey. It’s Time to Review the Three Rs, to Make them More Fit for Purpose in the 21st Century. Alternatives to Laboratory Animals. 2024;52(3):155-165. doi:10.1177/02611929241241187
Francesca Pistollato, Gregor Burkhart, Pierre Deceuninck, et al. What public health challenges and unmet medical needs would benefit from interdisciplinary collaboration in the EU? A survey and multi-stakeholder debate. Frontiers in Public Health. 2024;12:1417684. doi:10.3389/fpubh.2024.1417684
Nico D. Müller. Phase-out planning for animal experimentation: A definition, an argument, and seven action points. Alternatives to Animal Experimentation. 2024;41(2):260-272. doi:10.14573/altex.2312041